Purpose

Senate Standing Committee on Health
Senator Kemp Hannon, Chair
12 Noon, Tuesday, April 30, 2013
Room 123 CAP

PLEASE NOTE: The following bills have been placed on the agenda pursuant to Senate Rule VII, §3(e) - Motion for Committee Consideration:
S.2066

Printed No.

Sponsor

Title

270
Refer to Finance

Larkin

An act to amend the public health law, in relation to requiring facilities to perform pulse oximetry screening on newborns

2066
Refer to Insurance

Latimer

An act to amend the public health law, in relation to investigations of professional medical conduct

2190

Young

An act to amend the public health law, in relation to expanding the Doctors Across New York program to include dentists

2235

Golden

An act to amend the public health law, in relation to sales and purchases of human organs

2439
Refer to Finance

Klein

An act to amend the public health law, in relation to the inclusion of weight control in the health care and wellness education and outreach program; and to amend the insurance law, in relation to wellness programs

2750
Refer to Finance

Hannon

An act to amend the public health law, in relation to requiring hospitals to offer hepatitis C testing

3768
Refer to Finance

Hannon

An act to amend the public health law, in relation to breast cancer research

3926

Hannon

An act to amend the public health law, in relation to patient notice of the provision of observation services

3947
Refer to Consumer Protection

Grisanti

An act to amend the public health law, in relation to regulating heavy metals, magnets and batteries in children's jewelry; and providing for the repeal of such provisions upon expiration thereof

4325A

Perkins

An act to amend chapter 192 of the laws of 2011, relating to authorizing certain health care professionals licensed to practice in other jurisdictions to practice in this state in connection with an event sanctioned by New York Road Runners, in relation to extending the provisions thereof

4414

Hannon

An act to amend the public health law, in relation to designating Carbapenem-resistant Enterobacteriaceae (CRE) as a communicable disease and requiring general hospitals to identify and track the incidence of such communicable disease in accordance with the hospital acquired infection reporting system